Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAOLO STRATI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1154737765
CMS profile
6605357
Location
HOUSTON, TX

General Payments · PY2020–2024

$124,010.71

  • Reported across 141 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$44,121.61

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genmab U.S., Inc. $15,994.37 14
ABBVIE INC. $6,652.88 9
SWEDISH ORPHAN BIOVITRUM AB $6,292.10 2
BeiGene USA, Inc. $4,711.67 3
ADC Therapeutics America, Inc. $2,706.86 11
Genentech USA, Inc. $2,340.93 4
Acerta Pharma LLC $2,055.00 1
F. Hoffmann-La Roche AG $1,900.00 1
BTG INTERNATIONAL, INC. $1,067.63 2
Kite Pharma, Inc. $168.85 3
SOBI, INC $119.04 1
NOVARTIS PHARMACEUTICALS CORPORATION $112.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $20.87 1
PY2021 $2,615.93 5
PY2022 $25,483.54 44
PY2023 $51,768.76 39
PY2024 $44,121.61 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.17 04/05/2024 Food and Beverage Undisputed 01/23/2026 1106171977 CMS
ABBVIE INC. $142.55 06/02/2024 Food and Beverage Undisputed 01/23/2026 1106171979 CMS
ABBVIE INC. $725.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1106171981 CMS
ABBVIE INC. $4,350.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 1106171983 CMS
ABBVIE INC. $785.42 07/01/2024 Consulting Fee Undisputed 01/23/2026 1106171985 CMS
ABBVIE INC. $17.24 07/18/2024 Food and Beverage Undisputed 01/23/2026 1106171987 CMS
ABBVIE INC. $126.21 09/05/2024 Food and Beverage Undisputed 01/23/2026 1106171989 CMS
ABBVIE INC. $362.50 11/04/2024 Consulting Fee Undisputed 01/23/2026 1106171991 CMS
ABBVIE INC. $122.79 12/06/2024 Food and Beverage Undisputed 01/23/2026 1106171993 CMS
ADC Therapeutics America, Inc. $1,400.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1121186500 CMS
ADC Therapeutics America, Inc. $370.36 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1121186568 CMS
ADC Therapeutics America, Inc. $120.19 09/05/2024 Food and Beverage Undisputed 01/23/2026 1121186450 CMS
ADC Therapeutics America, Inc. $143.89 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121186544 CMS
ADC Therapeutics America, Inc. $49.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121186546 CMS
ADC Therapeutics America, Inc. $64.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121186548 CMS
ADC Therapeutics America, Inc. $39.00 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121186550 CMS
ADC Therapeutics America, Inc. $69.29 10/04/2024 Food and Beverage Undisputed 01/23/2026 1121186552 CMS
ADC Therapeutics America, Inc. $276.64 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1121186564 CMS
ADC Therapeutics America, Inc. $84.93 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1121186570 CMS
ADC Therapeutics America, Inc. $89.56 12/07/2024 Food and Beverage Undisputed 01/23/2026 1121186468 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1105545049 CMS
BeiGene USA, Inc. $4,500.00 03/26/2024 Consulting Fee Undisputed 01/23/2026 1120852645 CMS
BeiGene USA, Inc. $127.74 04/05/2024 Food and Beverage Undisputed 01/23/2026 1120852641 CMS
BeiGene USA, Inc. $83.93 06/03/2024 Food and Beverage Undisputed 01/23/2026 1120852643 CMS
BTG International, Inc. $67.63 07/26/2024 Food and Beverage Undisputed 01/23/2026 1126179066 CMS
BTG International, Inc. $1,000.00 08/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1126179068 CMS
F. Hoffmann-La Roche AG $1,900.00 09/26/2024 Consulting Fee Undisputed 01/23/2026 1133084922 CMS
Genentech USA, Inc. $51.65 06/15/2024 Food and Beverage Undisputed 01/23/2026 1133084910 CMS
Genentech USA, Inc. $2,185.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1133084918 CMS
Genentech USA, Inc. $71.63 12/07/2024 Food and Beverage Undisputed 01/23/2026 1133084906 CMS
Genentech USA, Inc. $32.65 12/09/2024 Food and Beverage Undisputed 01/23/2026 1133084914 CMS
Genmab U.S., Inc. $144.53 01/22/2024 Food and Beverage Undisputed 01/23/2026 1126830538 CMS
Genmab U.S., Inc. $938.70 01/22/2024 Travel and Lodging Undisputed 01/23/2026 1126830544 CMS
Genmab U.S., Inc. $874.65 01/22/2024 Travel and Lodging Undisputed 01/23/2026 1126830546 CMS
Genmab U.S., Inc. $375.02 01/23/2024 Travel and Lodging Undisputed 01/23/2026 1126830542 CMS
Genmab U.S., Inc. $6,750.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1126830540 CMS
Genmab U.S., Inc. $56.55 02/28/2024 Food and Beverage Undisputed 01/23/2026 1126830548 CMS
Genmab U.S., Inc. $117.35 06/15/2024 Food and Beverage Undisputed 01/23/2026 1126830550 CMS
Genmab U.S., Inc. $2,437.50 07/15/2024 Consulting Fee Undisputed 01/23/2026 1126830554 CMS
Genmab U.S., Inc. $225.87 07/15/2024 Food and Beverage Undisputed 01/23/2026 1126830556 CMS
Genmab U.S., Inc. $55.23 07/16/2024 Food and Beverage Undisputed 01/23/2026 1126830552 CMS
Genmab U.S., Inc. $3,937.50 10/26/2024 Consulting Fee Undisputed 01/23/2026 1126830558 CMS
Genmab U.S., Inc. $14.10 10/26/2024 Travel and Lodging Undisputed 01/23/2026 1126830560 CMS
Genmab U.S., Inc. $53.45 10/26/2024 Food and Beverage Undisputed 01/23/2026 1126830562 CMS
Genmab U.S., Inc. $13.92 10/26/2024 Travel and Lodging Undisputed 01/23/2026 1126830564 CMS
Kite Pharma, Inc. $37.65 02/22/2024 Food and Beverage Undisputed 01/23/2026 1128613555 CMS
Kite Pharma, Inc. $125.00 02/22/2024 Food and Beverage Undisputed 01/23/2026 1128613557 CMS
Kite Pharma, Inc. $6.20 08/27/2024 Food and Beverage Undisputed 01/23/2026 1128613559 CMS
Novartis Pharmaceuticals Corporation $112.28 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087341681 CMS
SOBI, INC $119.04 09/26/2024 Food and Beverage Undisputed 01/23/2026 1141436969 CMS
SWEDISH ORPHAN BIOVITRUM AB $4,625.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 1146408956 CMS
SWEDISH ORPHAN BIOVITRUM AB $1,667.10 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1146408964 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.